projects/cleopatra-ai
Project#1923 BY REVENUE FOR SALE
Cleopatra AI

Cleopatra AI

· via revenuecat
$550
Revenue · 30d
$3K
Total lifetime
$7K
Est. ARR
90%
Profit margin
Revenue trend
JUN 19
start
JUN 22
JUN 29
13.7%
JUL 6
9.6%
JUL 13
unchanged
JUL 20
next
no change recorded across the last 2 snapshots · figure may be stale at the source
https://apps.apple.com/app/id6752777484
Cleopatra AI
REVENUE VERIFIED
This project is for sale
$30K
Asking price
4.5x
Annual revenue
$550
Revenue · 30d
View listing

About Cleopatra AI

Cleopatra AI is a mobile application designed specifically for nose editing and rhinoplasty simulations. It allows users to reshape, retouch, and visualize potential nose job results through realistic previews. The app is focused on editing only the nose area, providing tools for fixing nose humps, refining the nose tip, adjusting width, and correcting asymmetry, all while maintaining facial harmony. Users can upload a clear photo, apply various editing filters, and compare before-and-after images to aid in decision-making before consulting with a plastic surgeon.

Notable features of Cleopatr…

VibeCrowd AI
Investment companion
AI analysis
Cleopatra AI is a revenue-stage mobile app that simulates cosmetic alterations, generating $550 in the last 30 days with $463 MRR, a very high reported margin (90%) but a recent drop of -18%, and it is currently listed for sale.

The app has real paying users and a subscription footprint (MRR $463), which is the strongest signal here — it’s not a prototype. However, the business is small in absolute scale ($550) and showed a month-over-month contraction (-18%), so momentum is a clear short-term risk. The reported margin (90%) is unusually high, implying low operating costs or capital-light delivery, which helps make the current revenue more defensible while growth is addressed.

For a founder, the immediate play is regaining positive growth: prioritize top-of-funnel traffic and conversion, or raising ARPU via premium features or B2B partnerships with clinics. For someone evaluating acquisition or backing, this is a compact, margin-efficient asset with paying customers but limited scale — the sale listing could be an opportunity, but confirm retention, CAC, and why the founder is exiting before pricing it as a growth asset.

Strengths

Has paying customers and recurring revenue ($463)
High reported profit margin (90%) reduces cash burn pressure
Clear product utility: mobile AI simulations for cosmetic procedure consideration

What to watch

Small absolute revenue run-rate ($550) limits runway without growth or external capital
Recent 30-day decline of -18% indicates churn or weakening acquisition
Currently listed for sale — good for buyers but requires diligence on why the business is being sold

Best suited for

Medical-aesthetics clinics or plastic-surgery groups wanting a patient-facing demo tool
Acquirers seeking small, margin-efficient AI consumer apps to bolt onto a larger portfolio
Founders or operators who can quickly invest in growth/marketing to re-accelerate traction

A judgment from project data — not a user review.

Generated by VibeCrowd AI from on-platform data·not financial advice·Jul 2026

Traffic & economics

90%
Profit margin · 30d
No reviews yet
Used Cleopatra AI? Be the first to share an honest review and help others decide.
No questions yet
Curious about pricing, features, or fit? Ask the first question.